D-310-2013 Class III Terminated
FDA drug recall D-310-2013 was initiated by Reckitt Benckiser Inc on Mar 18, 2013 and is designated Class III. Reason for recall: Subpotent Drug: Product did not conform to the 18-month stability test specification for active Free Benzocaine. The recall status is terminated (terminated Aug 14, 2014). Affected quantity: 27,718 cases 16 count and 7,551 cases 576 count.
Recall details
- Product Type
- Drugs
- Report Date
- May 8, 2013
- Initiation Date
- Mar 18, 2013
- Termination Date
- Aug 14, 2014
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 27,718 cases 16 count and 7,551 cases 576 count
Product description
Cherry Cepacol Sore Throat Lozenges, Benzocaine 15 mg | Menthol 3.6 mg, a)16-count, NDC 63824-711-16 b) Institutional Size, 576-count, NDC 63824-711-98, OTC, Dist. by: Reckitt Benckiser, Parsippany, NJ 07054
Reason for recall
Subpotent Drug: Product did not conform to the 18-month stability test specification for active Free Benzocaine.
Distribution pattern
Nationwide
Code information
16 count: AG156 Exp 11/13, AG257 Exp 12/13, AH388 02/14, AJ167 03/14, AL367 Exp 05/14, AL555 & AL568 Exp 06/14, AM141 Exp 07/14. 576 Count: AK505 Exp 04/14, AK570 Exp 05/14, AH368 & AH398 Exp 02/14, AJ000 Exp 03/14, AG596 Exp 12/13,
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-310-2013
- openFDA file date
- Nov 19, 2026
- Loaded by RegDataLab
- Nov 20, 2026
Need the full FDA record for Reckitt Benckiser Inc? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.